We are live on
!
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
Turnover
18.82%
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter
Est. Return
+1.69%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$353M
AUM Growth
+$22.9M
(+6.9%)
Cap. Flow
+$20.2M
Cap. Flow
% of AUM
5.72%
Top 10 Holdings %
Top 10 Hldgs %
40.34%
Holding
104
New
6
Increased
21
Reduced
24
Closed
10
Avg Time Held
3.8
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$7.97M |
| 2 |
JPMorgan Chase
JPM
|
+$7.83M |
| 3 |
AbbVie
ABBV
|
+$6.04M |
| 4 |
NVIDIA
NVDA
|
+$4.32M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$4.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$8.91M |
| 2 |
DuPont de Nemours
DD
|
+$6.22M |
| 3 |
ExxonMobil
XOM
|
+$1.25M |
| 4 |
Paramount Global Class B
PARA
|
+$780K |
| 5 |
Fortive
FTV
|
+$486K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.55% |
| 2 | Technology | 17.29% |
| 3 | Communication Services | 13.62% |
| 4 | Industrials | 12.57% |
| 5 | Energy | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Lockheed Martin
LMT
$126B
| $5.89M | 1.67% |
16,206
+38
| +0.2% | +$12.7K |
2013 Q2
24 quarters
|
|
27
Stryker
SYK
$113B
| $5.02M | 1.42% |
24,435
-100
| -0.4% | -$19.1K |
2016 Q1
13 quarters
|
|
28
Canadian National Railway
CNI
$73.6B
| $4.96M | 1.4% |
53,662
-6
| -0% | -$551 |
2013 Q2
24 quarters
|
|
|
29
NVIDIA
NVDA
$5.23T
| $4.28M | 1.21% |
+1,043,520
| New | +$4.32M |
2019 Q2
0 quarters
|
|
|
KSU
30
DELISTED
Kansas City Southern
KSU
| $4.25M | 1.2% |
34,860
+85
| +0.2% | +$10.2K |
2019 Q1
1 quarter
|
|
31
LyondellBasell Industries
LYB
$20.7B
| $4.23M | 1.2% |
49,094
| – | – |
2017 Q3
7 quarters
|
|
|
XLNX
32
DELISTED
Xilinx Inc
XLNX
| $4.18M | 1.18% |
+35,458
| New | +$4.13M |
2019 Q2
0 quarters
|
|
|
UBA
33
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $3.3M | 0.93% |
157,030
| – | – |
2013 Q2
24 quarters
|
|
34
Karyopharm Therapeutics
KPTI
$8.06M
| $3.16M | 0.89% |
35,127
+5,467
| +18% | +$439K |
2018 Q2
4 quarters
|
|
35
EOG Resources
EOG
$81.1B
| $2.82M | 0.8% |
30,293
| – | – |
2013 Q2
24 quarters
|
|
36
Alphabet (Google) Class C
GOOG
$4.18T
| $2.51M | 0.71% |
46,400
+3,720
| +9% | +$215K |
2013 Q2
24 quarters
|
|
37
Chevron
CVX
$435B
| $2.34M | 0.66% |
18,815
-126
| -0.7% | -$15.2K |
2013 Q2
24 quarters
|
|
38
iShares Select Dividend ETF
DVY
$23.2B
| $2.31M | 0.65% |
23,175
| – | – |
2013 Q2
24 quarters
|
|
39
Abbott
ABT
$181B
| $2.21M | 0.62% |
26,250
| – | – |
2013 Q2
24 quarters
|
|
40
Amazon
AMZN
$2.74T
| $2.07M | 0.59% |
21,840
+20
| +0.1% | +$1.86K |
2016 Q3
11 quarters
|
|
41
Charter Communications
CHTR
$12.5B
| $1.87M | 0.53% |
4,721
| – | – |
2013 Q2
24 quarters
|
|
42
Intuit
INTU
$87B
| $1.61M | 0.45% |
6,150
| – | – |
2013 Q2
24 quarters
|
|
43
Ball Corp
BALL
$16.8B
| $1.42M | 0.4% |
20,260
| – | – |
2013 Q2
24 quarters
|
|
|
44
Fortive
FTV
$17.6B
| $1.37M | 0.39% |
26,635
-9,356
| -26% | -$486K |
2016 Q3
11 quarters
|
|
|
45
ExxonMobil
XOM
$723B
| $1.35M | 0.38% |
17,608
-16,122
| -48% | -$1.25M |
2013 Q2
24 quarters
|
|
46
Omnicom Group
OMC
$22.4B
| $1.31M | 0.37% |
16,000
| – | – |
2013 Q2
24 quarters
|
|
47
Netflix
NFLX
$296B
| $1.29M | 0.36% |
35,000
| – | – |
2015 Q1
17 quarters
|
|
48
DELISTED
Liberty Broadband Class C
LBRDK
| $1.2M | 0.34% |
11,509
-2,536
| -18% | -$250K |
2014 Q4
18 quarters
|
|
49
Fiserv Inc
FISV
$25.1B
| $1.11M | 0.31% |
12,200
| – | – |
2013 Q2
24 quarters
|
|
50
Johnson & Johnson
JNJ
$618B
| $931K | 0.26% |
6,682
| – | – |
2013 Q2
24 quarters
|
|
Similar funds
WB
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Private Capital Advisors held 104 positions worth $353M, up 6.9% from $330M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Private Capital Advisors deployed $20.2M of net new capital in Q2 2019, opening 6 new positions and adding to 21 existing holdings. Its largest new stake was Northrop Grumman: 26,750 shares worth $8.64M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 31% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was ExxonMobil, an estimated $1.25M trimmed.
- Private Capital Advisors's largest Q2 2019 buy was Northrop Grumman: 26,750 shares worth $8.64M.
- Private Capital Advisors added most to AbbVie in Q2 2019, an estimated $6.04M increase.
- Private Capital Advisors's biggest Q2 2019 reduction was ExxonMobil, cutting an estimated $1.25M.
- Private Capital Advisors fully exited iShares Biotechnology ETF in Q2 2019, selling an estimated $8.91M.
- Private Capital Advisors's ten largest holdings make up 40% of its $353M portfolio in Q2 2019.
- Private Capital Advisors opened 6 new positions and closed 10 in Q2 2019.
- Private Capital Advisors's portfolio value rose 6.9% quarter-over-quarter to $353M.
Based on Private Capital Advisors's 13F filing for Q2 2019, filed 18 Jul 2019.